Dexlansoprazole is a new generation proton pump inhibitor (PPI) used for the management of symptoms associated with gastroesophageal reflux disease (GERD) and erosive esophagitis. Dexlansoprazole is the R-enantiomer of Lansoprazole, which is composed of a racemic mixture of the R- and S-enantiomers. Compared to the older generation of PPIs (which includes Pa...
Dexlansoprazole is a proton pump inhibitor (PPI) indicated in patients 12 years of age and older for:
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.